US Patent 7125865 Therapeutic compounds for treating dyslipidemic conditions
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
A. Brian Jones0
Ahren I. Green0
Alan D. Adams0
Bruno Tse0
Clare E. Gutteridge0
Shaei Y. Huang0
Yuan Cheng0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+263 characters)
Article
Patent abstract
The present invention relates to novel LXR ligands of Formula I and the pharmaceutically acceptable salts, esters and tautomers thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07125865 Therapeutic compounds for treating dyslipidemic conditions US Patent 7125865 Therapeutic compounds for treating dyslipidemic conditions
Infobox
Patent Number
071258650
Patent Number
71258650
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071258650
Date of Patent
October 24, 2006
0Patent Application Number
105221140
Date Filed
July 21, 2003
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07125865 Therapeutic compounds for treating dyslipidemic conditions
Infobox
Is a
Patent jurisdiction
Patent number
07125865
Date of patent
October 24, 2006
Patent application number
10522114
Date Filed
July 21, 2003
Patent primary examiner
Find more entities like US Patent 7125865 Therapeutic compounds for treating dyslipidemic conditions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
